NASDAQ
BioXcel Therapeutics, Inc. (BTAI) has a current ratio of 0.83x as of Monday, May 25, 2026. This represents a 86.58% decrease compared to its 12-month average of 6.18x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.